Onconano Medicine

About:

OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.

Website: https://www.onconano.com

Twitter/X: onconano

Top Investors: Cancer Prevention and Research Institute of Texas, Salem Partners, Advantech Capital, Adam Okun

Description:

OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue. OncoNano Medicine is a UTSW spinoff company based in Dallas, Texas.

Total Funding Amount:

$188M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Southlake, Texas, United States

Founded Date:

2014-12-29

Contact Email:

info(AT)onconanomed.com

Founders:

Ravi Srinivasan

Number of Employees:

11-50

Last Funding Date:

2021-10-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai